Immortal time bias or sorafenib effect in elderly patients with HCC?
- PMID: 28510340
- DOI: 10.1002/hep.29250
Immortal time bias or sorafenib effect in elderly patients with HCC?
Comment in
-
Reply.Hepatology. 2017 Aug;66(2):679-680. doi: 10.1002/hep.29248. Epub 2017 Jun 28. Hepatology. 2017. PMID: 28470664 No abstract available.
Comment on
-
Survival and cost-effectiveness of sorafenib therapy in advanced hepatocellular carcinoma: An analysis of the SEER-Medicare database.Hepatology. 2017 Jan;65(1):122-133. doi: 10.1002/hep.28881. Epub 2016 Nov 25. Hepatology. 2017. PMID: 27770556
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources